Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019
Thu, March 28, 2019
Wed, March 27, 2019
Tue, March 26, 2019

Alethia Young Maintained (ASND) at Buy with Decreased Target to $139 on, Mar 29th, 2019

Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $151 to $139 on, Mar 29th, 2019.

Alethia has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Joseph Schwartz of "Leerink Swann" Upgraded from Hold to Buy and Increased Target to $90 on, Thursday, January 24th, 2019